GGrantIndex
Sort

11,323 grants matching glioblastoma

Targeting the Urokinase Receptor in Glioblastoma Multiforme

$321,625
Steven L. Gonias · University Of California, San Diego · R01 · FY2015 · CA

The Fn14 Receptor and Brain Tumor Invasion

$321,596
Jeffrey A Winkles · University Of Maryland Baltimore · R01 · FY2010 · NS

Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma

$321,563
Xiaosi Han · University Of Alabama At Birmingham · R01 · FY2015 · NS

Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma

$321,563
Xiaosi Han · University Of Alabama At Birmingham · R01 · FY2018 · NS

Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma

$321,563
Xiaosi Han · University Of Alabama At Birmingham · R01 · FY2017 · NS

Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma

$321,563
Xiaosi Han · University Of Alabama At Birmingham · R01 · FY2016 · NS

Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma

$321,563
Xiaosi Han · University Of Alabama At Birmingham · R01 · FY2019 · NS

Visualizing EBV and HCMV DNA Dynamics During Infection

$321,539
William M. Sugden · University Of Wisconsin-Madison · P01 · FY2015 · CA

Molecular Regulation and Biological Functions of PIKE-A

$321,538
Keqiang Ye · Emory University · R01 · FY2008 · CA

NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)

$321,522
Elaine R Mardis · Washington University · U01 · FY2014 · GM

Project 1: Arming Oncolytic HSV Vectors to Improve Virolysis in Syngeneic Mouse Models of GBM

$321,473
Joseph C. Glorioso · Brigham And Women'S Hospital · P01 · FY2019 · CA

OSU-03012 therapy for glioblastoma

$321,410
Paul Dent · Virginia Commonwealth University · R01 · FY2010 · CA

Research Training Program in Neuro-Oncology

$321,308
Brian Patrick O'Neill · Mayo Clinic Rochester · T32 · FY2022 · CA

Phase I Study of Dendritic Cell Immunotherapy

$321,300
University Of California Los Angeles · R21 · FY2001 · CA

HEF1 Coordination of Cell Cycle, Migration, and Invasion in Cancer

$321,275
Erica A Golemis · Research Inst Of Fox Chase Can Ctr · R01 · FY2009 · CA

The San Francisco Bay Area Adult Glioma Survival Study

$321,228
Margaret R. Wrensch · University Of California, San Francisco · P50 · FY2007 · CA

Nanofiber matrices to improve neural stem cell-mediated cancer therapy

$321,130
Shawn Hingtgen · Univ Of North Carolina Chapel Hill · R01 · FY2016 · NS

Improving therapy of glioblastoma multiforme by enhancing therapeutic drug delive

$321,072
Michael R McDevitt · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA

MDA-7/IL-24: Therapy of Malignant Glioma

$320,989
Paul Dent · Columbia University Health Sciences · P01 · FY2007 · CA

INTERACTIONS OF FIBRINOGEN WITH p75NTR

$320,943
Katerina Akassoglou · J. David Gladstone Institutes · R01 · FY2008 · NS

Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9

$320,942
John J Laterra · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2014 · NS

Small Molecule Antibody Mimics: Toward a New Paradigm in Targeted Cancer Therapy

$320,875
David Adam Spiegel · Yale University · R01 · FY2012 · GM

RECEPTOR/LIGAND INTERACTIONS OF DEVELOPING OLIGODENDROCYTES

$320,794
University Of Pennsylvania · P01 · FY2000 · NS

Characterization of tetraspanin-EWI protein complexes and functions

$320,740
Martin E Hemler · Dana-Farber Cancer Inst · R01 · FY2010 · GM

Co-targeting mTOR and YAP signaling in glioblastoma

$320,662
Joseph F Gera · Brentwood Biomedical Research Institute · R01 · FY2020 · CA